Strip of 15 Units
Old MRP ₹98.8
MRP ₹92.62
₹77.99
₹6.17/Units
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionSitawok 50 Tablet 15 is used to manage Type 2 Diabetes by increasing insulin release and decreasing glucagon levels in the blood, which helps lower blood sugar after meals. By stabilizing blood sugar levels, it helps reduce the risk of long-term diabetic complications such as kidney damage, nerve pain, and vision problems. It is often prescribed when diet and exercise alone are not enough to maintain healthy glucose levels.
Sitawok 50 Tablet 15 is used to improve glycemic control in adults with Type 2 Diabetes Mellitus when combined with diet and exercise. It helps reduce the risk of long-term diabetic complications associated with uncontrolled blood sugar levels. By improving blood glucose control, it supports overall metabolic health, but it should be used as part of a comprehensive diabetes management plan advised by a doctor.
Swallow the tablet whole with a glass of water.
Do not break, chew, or crush the tablet.
Aim to take your medicine at the same time each day.
Sitawok 50 Tablet 15 is taken orally.
Sitawok 50 Tablet 15 may lead to headache, joint pain, upper respiratory tract infections, nasopharyngitis, low blood sugar levels, and, rarely, kidney-related issues.
Most side effects are temporary, usually mild, and resolve upon discontinuing the use of Sitawok 50 Tablet 15. However, if you experience serious side effects or worsening of any of the symptoms, consult your doctor.
Here are some helpful tips for handling common side effects:
Headache: Ensure you rest well and keep yourself hydrated. Avoid exposure to loud sounds or bright lights.
Hypoglycaemia: If you have symptoms like shakiness, sweating, or dizziness, consume a quick source of sugar, like fruit juice or hard candies.
Sitawok 50 Tablet 15 contains sitagliptin (50 mg), which acts on the body in the following ways:
DPP-4 inhibition: Sitagliptin works by blocking an enzyme in your body known as DPP-4, or dipeptidyl peptidase 4. This enzyme is normally responsible for breaking down certain hormones that help regulate insulin levels.
Regulation of blood sugar: By inhibiting DPP-4, sitagliptin increases and prolongs the action of these hormones, leading to higher insulin levels and lower glucagon levels when blood sugar is high. This helps to control both fasting and post-meal blood glucose levels.
Caution is advised while taking Sitawok 50 Tablet 15 if you are pregnant. It is best to consult your doctor before taking this medicine.
Exercise caution while taking Sitawok 50 Tablet 15 if you are breastfeeding. Discuss this with your doctor to understand the potential risks and benefits before taking this medication.
Drinking alcohol while on Sitawok 50 Tablet 15 may increase your risk of low blood sugar, especially if you are also on insulin or sulfonylurea medicines. It's advisable to limit alcohol consumption while taking this medicine.
Patients with liver problems can use Sitawok 50 Tablet 15, but it's always wise to discuss any liver-related concerns with your doctor before starting this medication.
For those with mild to moderate kidney impairment, no dosage adjustment of Sitawok 50 Tablet 15 is required. However, it's not recommended for severe kidney conditions or those requiring dialysis. Always discuss kidney health issues with your doctor before starting this medicine.
Sitawok 50 Tablet 15 does not usually affect your ability to drive or operate machines. However, if you feel unwell after taking it, avoid such activities until you feel better.
If you have a history of serious hypersensitivity reaction to sitagliptin or any other ingredients in Sitawok 50 Tablet 15, do not take this medicine. Your doctor can recommend alternatives.
Sitawok 50 Tablet 15 is not meant for use in children under the age of 18. Always consult your doctor before giving any medicine to a child.
Older patients should take Sitawok 50 Tablet 15 under medical supervision, as they may be more prone to its side effects. If you are over the age of 70, it's wise to consult your doctor before starting this medicine.
Sitawok 50 Tablet 15 interacts with the following medicines:
Antidiabetic medicines: Medicines like insulin and sulfonylureas like glimepiride and glibenclamide may interact with Sitawok 50 Tablet 15, potentially increasing the risk of low blood sugar or hypoglycaemia.
Cardiac glycosides: Medicines like digoxin might interact with Sitawok 50 Tablet 15, leading to a slight increase in plasma concentrations of digoxin.
None
Sitawok 50 Tablet 15 interacts with the following diseases:
Kidney disease: People with kidney disease should use Sitawok 50 Tablet 15 with caution, as it may worsen their condition.
Pancreatitis: If you've previously had pancreatitis or gallstones, Sitawok 50 Tablet 15 might increase your risk of developing pancreatitis again.
Heart disease: If you have heart disease, consult your doctor before starting this medication, as it may need careful monitoring.
High triglyceride levels: If you have high triglyceride levels in your blood, be cautious while taking this medicine and inform your doctor about it beforehand.
Your doctor will prescribe the recommended dose of Sitawok 50 Tablet 15, considering your specific health condition and your body's response to the medicine. Stick to the prescribed dosage and avoid exceeding it without consulting your doctor.
An overdose of Sitawok 50 Tablet 15 may cause symptoms like headaches or cold-like symptoms. If you've taken more than the recommended dose and start feeling unwell, inform your doctor promptly.
If you forget to take your Sitawok 50 Tablet 15, take it as soon as you remember. However, if it's nearly time for your next dose, skip the missed one and stick to your regular schedule. Never adjust your dosage without consulting your doctor.
Store Sitawok 50 Tablet 15 at room temperature, ideally below 30°C.
Keep it shielded from dampness and moisture.
Place it in a location out of reach of children.
Always check the expiration date before use.
Maintain a balanced diet that's low in sugar and carbohydrates. This can help manage your blood sugar levels, complementing the effects of Sitawok 50 Tablet 15.
Regular physical activity, like walking or cycling, is beneficial. Exercise aids in controlling blood glucose levels by helping your body use insulin more efficiently.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Type 2 Diabetes |
| Drug Category | DPP-4 Inhibitor |
| Therapeutic Category | Antidiabetic |
Sitawok 50 Tablet 15 is used to manage high blood sugar in adults with type 2 diabetes when diet, exercise, and single medicinal therapy are inadequate.
Sitawok 50 Tablet 15 contains sitagliptin, which works by regulating insulin levels and controlling high blood sugar.
Yes, Sitawok 50 Tablet 15 can be taken with other antidiabetic medications, such as metformin and sulfonylureas, but always consult your doctor first.
Common side effects include upper respiratory tract infection, nasopharyngitis, headaches, and hypoglycaemia.
Take Sitawok 50 Tablet 15 orally as advised by your doctor. It can be taken with or without food at any time of the day.
Inform your doctor if you have or have ever had pancreatitis, gallstones, kidney disease, heart disease, or high triglyceride levels before starting this medicine.
Alcohol can increase the risk of hypoglycaemia, especially if you are already taking other antidiabetic medicines. It is advisable to avoid consuming alcohol while on Sitawok 50 Tablet 15.
Check out Editorial Policy
U.S. Food and Drug Administration. (2023, Oct). Zituvio (sitagliptin) tablets label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf
U.S. Food and Drug Administration. (2022, Jun). Januvia (sitagliptin) tablets label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf
U.S. Food and Drug Administration. (2006, Oct 16). Drug Approval Package - Januvia (sitagliptin phosphate) tablets. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021995s000TOC.cfm
AHFS Patient Medication Information [Internet]. (2024, Feb 15). Sitagliptin – MedlinePlus Drug Information. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a606023.html
National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 4369359, Sitagliptin. https://pubchem.ncbi.nlm.nih.gov/compound/Sitagliptin
Scott L. J. (2017). Sitagliptin: A Review in Type 2 Diabetes. Drugs, 77(2), 209–224. https://doi.org/10.1007/s40265-016-0686-9
Gallwitz B. (2007). Review of sitagliptin phosphate: a novel treatment for type 2 diabetes. Vascular health and risk management, 3(2), 203–210. https://doi.org/10.2147/vhrm.2007.3.2.203
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
1961 users bought this instead
Read More
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.11.0
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
